Literature DB >> 18589869

Spontaneous vulvar papillomas in a colony of mice used for pancreatic cancer research.

Naomi M Gades1, Akihiro Ohash, Lisa D Mills, Matt A Rowley, Kelly S Predmore, Ronald J Marler, Fergus J Couch.   

Abstract

Mice in a colony used for pancreatic cancer research and maintained in a barrier animal facility presented with vulvar masses. A census and examination of all colony animals was conducted on 17 February 2006; line, gender, and mass location were recorded; a slide caliper was used to measure the width, length, and height of each mass; and the volume of each mass was calculated. Progeny female mice from crossbreeding of the B6.FVB-Tg(Ipf1-cre)1Tuv and B6;129-Kras2tm4Tyj (KRAS(G12D/+)) strains presented with external vulvar and periauricular papillomas. The papillomas were present in 41.2% of all female crossbred mice and ranged in size from 8 to 36 mm3. Age of mice and tumor size were not correlated. Compared with the B6.FVB-Tg(Ipf1-cre)1Tuv line, the crossbred female mice were more likely to have a vulvar mass, with an odds ratio of 29.3, 95% confidence interval (1.5, 563.9) and a positive predictive value of 42.9%. Diagnostic evaluation, including electron microscopy, light microscopy, serology, and bacteriology, did not reveal a viral or other infectious etiology. Therefore, we speculate that interaction between the genetic background of the mice and the introduced Kras oncogene may be responsible for these papillomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18589869      PMCID: PMC2704118     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  19 in total

1.  Genomic variation of the fibropapilloma-associated marine turtle herpesvirus across seven geographic areas and three host species.

Authors:  Rebecca J Greenblatt; Sandra L Quackenbush; Rufina N Casey; Joel Rovnak; George H Balazs; Thierry M Work; James W Casey; Claudia A Sutton
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Characterization of immune responses during regression of rabbit oral papillomavirus infections.

Authors:  Brian J Wilgenburg; Lynn R Budgeon; C Max Lang; James W Griffith; Neil D Christensen
Journal:  Comp Med       Date:  2005-10       Impact factor: 0.982

3.  Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.

Authors:  E M Simpson; C C Linder; E E Sargent; M T Davisson; L E Mobraaten; J J Sharp
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  A novel psittacid herpesvirus found in African grey parrots (Psittacus erithacus erithacus).

Authors:  Darrel K Styles; Elizabeth K Tomaszewski; David N Phalen
Journal:  Avian Pathol       Date:  2005-04       Impact factor: 3.378

5.  Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma.

Authors:  Hideaki Katori; Akinori Nozawa; Mamoru Tsukuda
Journal:  J Surg Oncol       Date:  2006-01-01       Impact factor: 3.454

6.  Correlation of histology, human papillomavirus, and viral load in laryngeal papillomas of childhood.

Authors:  Girishwar Sharma; Jonathan DeHart; Gerard J Nuovo
Journal:  Diagn Mol Pathol       Date:  2005-12

7.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

8.  Immortalization of inbred rabbit keratinocytes from a Shope papilloma and tumorigenic transformation of the cells by EJ-ras.

Authors:  X Peng; C M Lang; J W Kreider
Journal:  Cancer Lett       Date:  1996-11-12       Impact factor: 8.679

Review 9.  Genetic variables that influence phenotype.

Authors:  Carol Cutler Linder
Journal:  ILAR J       Date:  2006

Review 10.  Microbial considerations in genetically engineered mouse research.

Authors:  Craig L Franklin
Journal:  ILAR J       Date:  2006
View more
  5 in total

1.  Targeting eNOS in pancreatic cancer.

Authors:  Benjamin L Lampson; S Disean Kendall; Brooke B Ancrile; Meghan M Morrison; Michael J Shealy; Katharine S Barrientos; Matthew S Crowe; David F Kashatus; Rebekah R White; Susan B Gurley; Diana M Cardona; Christopher M Counter
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

2.  Vaginal Squamous Cell Carcinoma Develops in Mice with Conditional Arid1a Loss and Gain of Oncogenic Kras Driven by Progesterone Receptor Cre.

Authors:  Xiyin Wang; Mariana S L Praça; Jillian R H Wendel; Robert E Emerson; Francesco J DeMayo; John P Lydon; Shannon M Hawkins
Journal:  Am J Pathol       Date:  2021-04-18       Impact factor: 5.770

Review 3.  GEMMs as preclinical models for testing pancreatic cancer therapies.

Authors:  Aarthi Gopinathan; Jennifer P Morton; Duncan I Jodrell; Owen J Sansom
Journal:  Dis Model Mech       Date:  2015-10-01       Impact factor: 5.758

4.  STING expression and response to treatment with STING ligands in premalignant and malignant disease.

Authors:  Jason R Baird; Zipei Feng; Hong D Xiao; David Friedman; Ben Cottam; Bernard A Fox; Gwen Kramer; Rom S Leidner; R Bryan Bell; Kristina H Young; Marka R Crittenden; Michael J Gough
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

5.  Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.

Authors:  Jamie D Weyandt; Benjamin L Lampson; Sherry Tang; Matthew Mastrodomenico; Diana M Cardona; Christopher M Counter
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.